Wordt geladen...
Strategies for Optimizing the Clinical Impact of Immunotherapeutic Agents Such as Sipuleucel-T in Prostate Cancer
Sipuleucel-T is a therapeutic cancer vaccine that has shown improved survival in men with metastatic castration-resistant prostate cancer. As a first-in-class agent, it has been met with both fanfare and controversy. A broad review of immune-based therapies may reveal the delayed clinical impact of...
Bewaard in:
| Gepubliceerd in: | J Natl Compr Canc Netw |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599514/ https://ncbi.nlm.nih.gov/pubmed/23221788 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|